Reitman, Zachary J.
Paolella, Brenton R. http://orcid.org/0000-0003-3394-828X
Bergthold, Guillaume
Pelton, Kristine
Becker, Sarah
Jones, Robert
Sinai, Claire E.
Malkin, Hayley
Huang, Ying
Grimmet, Leslie
Herbert, Zachary T.
Sun, Yu
Weatherbee, Jessica L.
Alberta, John A.
Daley, John F.
Rozenblatt-Rosen, Orit
Condurat, Alexandra L.
Qian, Kenin
Khadka, Prasidda
Segal, Rosalind A.
Haas-Kogan, Daphne
Filbin, Mariella G.
Suva, Mario L. http://orcid.org/0000-0001-9898-5351
Regev, Aviv
Stiles, Charles D.
Kieran, Mark W.
Goumnerova, Liliana http://orcid.org/0000-0002-2662-719X
Ligon, Keith L.
Shalek, Alex K.
Bandopadhayay, Pratiti
Beroukhim, Rameen http://orcid.org/0000-0001-6303-3609
Funding for this research was provided by:
Pediatric Low Grade Astrocytoma Foundation
Article History
Received: 11 January 2019
Accepted: 10 July 2019
First Online: 19 August 2019
Competing interests
: P.B. and R.B. received grant funding from Novartis and R.B. has received consulting fees from Novartis. R.B. consults for and owns shares in Ampressa. A.R. is a scientific advisory board member for ThermoFisher Scientific, Syros Pharmaceuticals and Driver Group. A.K.S have received compensation for consulting and SAB membership from Honeycomb Biotechnologies, Cellarity, Cogen Therapeutics, and Dahlia Biosciences. M.W.K. is now an employee of Bristol-Myers Squibb. G.B. is now an employee of Roche. All the remaining authors declare no competing interests.